Nuchev Pty Ltd (AU:NUC) has released an update.
Nuchev Ltd has reported a strong fiscal year with a 45% increase in sales revenue for its Oli6 Nutritionals, alongside a significant acquisition of bWellness aimed at accelerating the company’s push to breakeven. The company has also improved its adjusted EBITDA by 20% and boasts a robust balance sheet with a closing cash position of $7.6 million and no external debt, underpinned by stringent working capital management and a successful capital raise.
For further insights into AU:NUC stock, check out TipRanks’ Stock Analysis page.
